Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Apellis Pharmaceuticals, Inc. (APLS)
Sector: Healthcare; Industry: Biotechnology

Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. Apellis Pharmaceuticals, Inc. was founded in 2009 and is headquartered in Crestwood, Kentucky.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-04-14 Grossi Federico CHIEF MEDICAL OFFICER Sell 500 $42.82 $21,410 No
2021-04-01 Grossi Federico CHIEF MEDICAL OFFICER Sell 600 $43.41 $26,046 No
2021-03-15 Machiels Alec Director Sell 2,500 $46.77 $116,925 Yes
2021-03-15 Grossi Federico CHIEF MEDICAL OFFICER Sell 500 $46.77 $23,385 No
2021-03-10 Deschatelets Pascal Chief Scientific Officer Sell 6,250 $50.74 $317,125 Yes
2021-03-05 Grossi Federico CHIEF MEDICAL OFFICER Sell 5,000 $48.62 $243,075 Yes
2021-03-01 Perry Nicole D Vice President - Accounting Sell 2,000 $50.00 $100,000 Yes
2021-03-01 Grossi Federico CHIEF MEDICAL OFFICER Sell 600 $48.58 $29,148 No
2021-02-16 Grossi Federico CHIEF MEDICAL OFFICER Sell 500 $46.00 $23,000 No
2021-02-16 Machiels Alec Director Sell 2,500 $46.00 $115,000 Yes
2021-02-09 Perry Nicole D Vice President - Accounting Sell 2,000 $50.00 $100,000 Yes
2021-02-01 Grossi Federico CHIEF MEDICAL OFFICER Sell 600 $44.00 $26,400 No
2021-01-15 Machiels Alec Director Sell 2,500 $53.15 $132,875 Yes
2021-01-14 Grossi Federico CHIEF MEDICAL OFFICER Sell 4,000 $51.99 $207,960 No
2021-01-04 Grossi Federico CHIEF MEDICAL OFFICER Sell 600 $57.24 $34,344 No
2021-01-04 Perry Nicole D Vice President - Accounting Sell 2,000 $57.24 $114,480 Yes
2020-12-15 Machiels Alec Director Sell 2,500 $52.16 $130,400 Yes
2020-12-15 Francois Cedric Chief Executive Officer Sell 5,000 $52.16 $260,800 No
2020-12-14 Dunlop A. Sinclair Director Sell 25,000 $54.67 $1,366,713 No
2020-12-14 Watson David O. General Counsel Sell 18,333 $50.94 $933,947 Yes
2020-12-04 Perry Nicole D Vice President - Accounting Sell 18,000 $50.00 $900,000 Yes
2020-12-07 Dunlop A. Sinclair Director Sell 25,000 $50.59 $1,264,854 No
2020-12-01 Grossi Federico CHIEF MEDICAL OFFICER Sell 600 $48.25 $28,950 No
2020-11-16 Francois Cedric Chief Executive Officer Sell 5,000 $39.38 $196,900 No
2020-11-16 Machiels Alec Director Sell 2,500 $39.38 $98,450 Yes
2020-11-02 Grossi Federico CHIEF MEDICAL OFFICER Sell 600 $31.09 $18,654 No
2020-10-15 Machiels Alec Director Sell 2,500 $35.00 $87,500 Yes
2020-10-15 Francois Cedric Chief Executive Officer Sell 5,000 $34.46 $172,300 No
2020-10-07 Machiels Alec Director Sell 7,500 $35.00 $262,500 Yes
2020-10-07 Brown Victoria L. Program Team Lead Sell 12,000 $35.00 $420,000 Yes

Insider Smart

Enphase Energy, Inc (ENPH) - ENPH was $10+ in 15Q1 then dropped to $2 and eventually went under $1. From 15Q4 to 17Q4 it built a 2-year-long base then BOOM! Stock went as high as $70 and likely will make a new high. Catch one or two moves like this you can retire early. One hint before the big move was that CEO and CFO were constantly accumulating, this kind of information is priceless.

Insider Smart

SYSCO CORP (SYY) - PELTZ NELSON and Frank Joshua D are insiders of SYSCO CORP, check their transactions to see how they sell high and buy low. Would that be more persuasive than just buy or sell?